Adicet Bio, Inc. (ACET) Earnings History
Net Loss18 years of earnings data (2008–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Adicet Bio, Inc. (ACET) Earnings Overview
As of June 13, 2026, Adicet Bio, Inc. (ACET) reported trailing twelve-month net income of -$109M, reflecting +20.3% year-over-year growth. The company earned $-10.13 per diluted share over the past four quarters.
Looking at the long-term picture, ACET's historical earnings data spans multiple years. The company achieved its highest annual net income of $29M in fiscal 2015.
Adicet Bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FATE (-$130M net income, -2051.1% margin), CELC (-$193M net income), TCRX (-$124M net income, -1256.8% margin), ACET has comparable earnings metrics. Compare ACET vs FATE →
ACET Earnings vs Peers
Earnings metrics vs comparable public companies
ACET Historical Earnings Data (2008–2025)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$117M | +0.3% | -$122M | $-16.95 | - | - |
| 2024 | -$117M | +17.9% | -$128M | $-21.28 | - | - |
| 2023 | -$143M | -104.4% | -$152M | $-52.96 | - | - |
| 2022 | -$70M | -12.6% | -$73M | $-27.20 | -279.3% | -290.3% |
| 2021 | -$62M | -69.0% | -$61M | $-32.00 | -637.2% | -631.4% |
| 2020 | -$37M | -30.4% | -$39M | $-80.16 | -204.9% | -218.9% |
| 2019 | -$28M | -202.6% | -$31M | $-24.32 | -2827.9% | -3154.6% |
| 2018 | -$9M | +72.5% | -$15M | $-4.96 | -113.7% | -182.9% |
| 2017 | -$34M | -3377700.0% | -$19M | $-20.00 | -6.0% | -3.4% |
| 2016 | $-1,000 | -100.0% | $-1,000 | $-0.00 | -0.0% | -0.0% |
| 2015 | $29M | +29.9% | $44M | $18.56 | 5.7% | 8.7% |
| 2014 | $22M | +0.0% | $34M | $14.88 | 4.5% | 6.9% |
| 2013 | $22M | +31.5% | $34M | $14.88 | 4.5% | 6.9% |
| 2012 | $17M | +89.4% | $25M | $11.52 | 3.8% | 5.7% |
| 2011 | $9M | +36.3% | $17M | $6.24 | 2.2% | 4.0% |
| 2010 | $7M | -23.7% | $9M | $4.80 | 1.9% | 2.7% |
| 2009 | $9M | -36.0% | $12M | $6.24 | 2.7% | 3.7% |
| 2008 | $13M | - | $21M | $9.92 | 3.7% | 5.9% |
Download Data
Export ACET earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in ACET back in 2008?
Total return with dividends reinvested · 18+ years of data
Calculate ReturnsHow much would $100/month in ACET be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs ACET Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationACET vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowACET — Frequently Asked Questions
Quick answers to the most common questions about buying ACET stock.
What is ACET earnings per share (EPS)?
ACET trailing twelve-month (TTM) diluted EPS is $-10.13, reflecting +20.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2008 to 2025 is available in the table on this page.
What is Adicet Bio, Inc.'s net income?
Adicet Bio, Inc. (ACET) trailing twelve-month net income is $-109M as of 2025. Earnings grew +20.3% year-over-year.
Is ACET profitable?
ACET is not currently profitable on a TTM basis, reporting a net loss of $-109M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ACET's earnings growth rate?
ACET compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2008 to 2025.
What are ACET's profit margins?
Adicet Bio, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -67.6%.
Is ACET growing earnings?
Yes, ACET earnings are accelerating — EPS growth of +20.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-109M. Earnings momentum is strengthening.
What was ACET's best earnings year?
Adicet Bio, Inc.'s highest annual net income on record is $29M, achieved in fiscal year 2015. Earnings history on this page spans 2008 to 2025 and includes all annual and quarterly figures.
What were ACET's earnings last quarter?
ACET's most recent reported quarter was Q1 2026. Net income was $-20M with diluted EPS of $-1.88. For a full breakdown of all quarters, see the quarterly earnings table on this page.